Financials
Financial year 2025
OFFIPHARMA from Froidchapelle, company number BE0864276532, closed financial year 2025 with a result of € -4,999 after tax. For that financial year OFFIPHARMA recorded a gross margin of € 124,712 and equity of € 261,127. Compared with financial year 2024, the result moved from € 19,192 to € -4,999. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 261,127
▼ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -4,999
▼ still € 19,192 profit in 2024
Profit after tax over the fiscal year.
€ 184,271
▼ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 242,527.
People and assets in 2025
1.5
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 118,410
▲ 2% vs 2024
€ 78,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 114,321
▲ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,310
▼ 11% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 203,435 | € 150,172 | € 157,990 | € 124,712 | ▼ 21% |
| Profit after taxes | € 62,694 | € 33,641 | € 19,192 | € -4,999 | ▼ € 24,191 |
| Equity | € 222,693 | € 246,934 | € 266,126 | € 261,127 | ▼ 2% |
| Total debts | € 135,874 | € 139,746 | € 127,389 | € 138,631 | ▲ 9% |
| Cash | € 167,419 | € 185,551 | € 188,824 | € 184,271 | ▼ 2% |
| Retained profit | € 204,093 | € 228,334 | € 247,526 | € 242,527 | ▼ 2% |
| Dividend | € 14,000 | € 9,400 | € 0 | € 0 | |
| Balance sheet total | € 358,567 | € 386,679 | € 393,514 | € 399,757 | ▲ 2% |
| Employees (FTE) | 1.4 | 1.5 | 1.4 | 1.5 | ▲ 0.1 |
Key figures of OFFIPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OFFIPHARMA?
What happened at OFFIPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 4,999 (▼ € 24,191 vs 2024). filed late Source: NBB ↗
- Brigitte RASKINET became a director. NBB
- New establishment in Froidchapelle. KBO
- Start of the company according to the CBE. KBO
In short
From € 62,694 profit in 2022 to € 4,999 loss in 2025.
Paid € 45,123 in corporate taxes since 2022.
Best year ever: 2022, with € 62,694 profit.
On average € 83,100 of value added per employee in 2025.
Management
Behind OFFIPHARMA is Brigitte RASKINET.
Directors
According to the 2025 annual accounts
Brigitte RASKINET
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Rue du Gouty(FRO) 22
6440 Froidchapelle
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0864.276.532
- VAT number
- BE 0864.276.532
- Registered office
- Rue du Gouty(FRO) 22, 6440 Froidchapelle
- Names & denominations
- OFFIPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 March 2004
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers